Acelot has dosed the first healthy volunteer in a Phase 1a clinical trial testing ACE-2223, its investigational oral treatment candidate designed to target aggregated TDP-43 in people with amyotrophic ...
Geneuro received a European patent for GNK-301, an antibody targeting K Env, with Phase 1 trials planned for the second half of 2027.
In 1980, a local hospital hired me to launch their brand-new wellness department. I knew it would be an uphill battle. Back ...
It’s a schtick we repeat whenever he needs to reorder something he buys in bulk, like gauze pads, deodorant, or gloves. He always feigns disappointment when we run out of something. “So irritating,” ...
Mindy Henderson has spent much of her life challenging the limits others have placed on her. When she was diagnosed with ...
Paradromics’ investigational Connexus brain-computer interface (BCI) enabled a woman with a progressive motor neuron disease to generate her own words in real time, answer open-ended questions, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results